This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Männistö, S. Articles by Virtamo, J. Search for Related Content PubMed PubMed Citation Articles by Männistö, S. Articles by Virtamo, J.

Fatty Acids and Risk of Prostate Cancer in a Nested Case-Control Study in Male Smokers

¹ Departments of Epidemiology and Health Promotion, and ² Health and Functional Capacity, National Public Health Institute, Helsinki, Finland; Departments of ³ Nutrition and ⁴ Epidemiology, Harvard School of Public Health, Boston, Massachusetts; ⁵ National Cancer Institute, NIH, Bethesda, Maryland; and ⁶ Department of Medicine, Harvard Medical School, Boston, Massachusetts

There is some evidence that -linolenic acid might be positively related to prostate cancer risk. Associations between serum fatty acid composition as well as fatty acid intakes and prostate cancer risk were examined in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The cohort included 29,133 male smokers aged 50–69 years. During 5–8 years of follow-up, 246 prostate cancer cases were diagnosed. One control was selected and matched by age (± 1 month) for each case from the cohort subjects alive and free of prostate cancer at the time the case was diagnosed. This study included 198 case-control pairs with baseline serum sample available for both. Fatty acids of serum cholesterol esters were measured as a percentage of total fatty acids, using capillary gas chromatography. Intakes of fatty acids were assessed from a validated self-administered dietary questionnaire. Serum and dietary fatty acids had no consistent association with prostate cancer risk. Serum -linolenic acid was not related to prostate cancer risk. Twofold risk was found in the highest quartile of serum myristic acid compared with the lowest quartile (odds ratio, 1.93; 95% confidence interval, 1.02–3.64). -Tocopherol supplementation modified the association between serum linoleic acid and prostate cancer risk (P for interaction 0.03); odds ratio was 0.17 (95% confidence interval, 0.04–0.68) in the highest quartile of serum linoleic acid compared with the lowest quartile in men who received -tocopherol, whereas no association was found in men who did not receive -tocopherol. In conclusion, we found no overall association between serum or dietary -linolenic acid or any other unsaturated fatty acid and prostate cancer risk, but high serum linoleic acid was associated with lower risk in men supplemented with -tocopherol. High serum myristic acid associated with an increased risk of prostate cancer.

This article has been cited by other articles:

				N. Kurahashi, M. Inoue, M. Iwasaki, S. Sasazuki, a. S. Tsugane, and for the Japan Public Health Center-Based Prospecti Dairy Product, Saturated Fatty Acid, and Calcium Intake and Prostate Cancer in a Prospective Cohort of Japanese Men Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 930 - 937. [Abstract] [Full Text] [PDF]

				P. D. Terry, J. B. Terry, and T. E. Rohan Long-Chain (n-3) Fatty Acid Intake and Risk of Cancers of the Breast and the Prostate: Recent Epidemiological Studies, Biological Mechanisms, and Directions for Future Research J. Nutr., December 1, 2004; 134(12): 3412S - 3420S. [Abstract] [Full Text] [PDF]

				L. K. Dennis, L. G. Snetselaar, B. J. Smith, R. E. Stewart, and M. E. C. Robbins Problems with the Assessment of Dietary Fat in Prostate Cancer Studies Am. J. Epidemiol., September 1, 2004; 160(5): 436 - 444. [Abstract] [Full Text] [PDF]